Protein Kinase Inhibitors

Autor: Carlos Perez Martinez, Jose Antonio Martinez Perez, David Andrew Coates, Concepcion Sanchez Martinez, Ana De Prado Gonzales, Miriam Filadelfa Del Prado Catalina, Alfonso De Dios Magana, Maria Dolores Martin Ortega Finger, Maria Cristina Garcia Paredes, John Monte Knobeloch, Ana Isabel Mateo Herranz, Eva Maria Martin De La Nava, Lawrence M. Gelbert
Rok vydání: 2010
Předmět:
Zdroj: Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures ISBN: 9789048197033
Popis: The present invention provides a compound incorporating a group of formula (I) wherein: 1 of X, Y and Z is nitrogen and the other 2 are carbon; V is sulpur or carbon; R 3 is oxygen or fluorine; R 4 is an optionally present C 1-3 alkyl group optionally substituted by fluorine; R 5 is an optionally present cyclic group with 5-7 heavy atoms in the ring which may be carbocyclic or heterocyclic and aromatic or aliphatic and is optionally substituted, e.g. by a halogen, C 1-2 alkyl or fluoroalkyl, OH, OR 6 , cyano, COOR 6 , CONHR 6 , sulfonamide or NHR 6 , in which R 6 is a C 1-2 alkyl or fluoroalkyl; at least one of R 4 and R 5 is present and R 4 and R 5 may both be present; m and n are each 1 or 2 depending on the identity of V and R 3 ; when n=2 each R 3 may be the same or different but are preferably the same, when m=2, each R 4 and each R 5 may be the same or different but are preferably the same; and W represents hydrogen, carbon, nitrogen, oxygen or sulphur; or incorporating a salt, hydrate or solvate of a group of formula (I); as well as therapeutic uses of these compounds, in particular as inhibitors of protein kinase activity and in the treatment of inflammation, inflammatory conditions and cancer.
Databáze: OpenAIRE